Type of intervention | Topics covered |
---|---|
Health policy interventions | SUPPORT summary: Do pharmaceutical reference and index pricing policies have effects on drug use, health care utilisation, health outcomes and costs? |
Health systems interventions | WHO guideline on prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people |
WHO guideline on retention of rural health workers | |
Various WHO guidelines on community-based newborn care | |
SUPPORT summary: Do conditional cash transfers improve the uptake of health interventions in low and middle-income countries? | |
SUPPORT summary: Does pay-for-performance improve the quality of health care? | |
SUPPORT summary: Does expanding the role of outpatient pharmacists improve healthcare delivery and patient outcomes? | |
SUPPORT summary: Does prompting physicians improve performance in preventive care? | |
Nutrition interventions | Guideline: Neonatal vitamin A supplementation |
Guideline: Vitamin A supplementation for infants 1–5 months of age | |
Guideline: Vitamin A supplementation for infants and children 6–59 months of age | |
Guideline: Vitamin A supplementation in pregnant women | |
Guideline: Vitamin A supplementation in postpartum women | |
Guideline: Vitamin A supplementation during pregnancy for reducing the risk of mother-to-child transmission of HIV | |
Guideline: Intermittent iron supplementation in preschool and school-age children | |
Guideline: Intermittent iron and folic acid supplementation in menstruating women | |
Guideline: Daily iron and folic acid supplementation in pregnant women (in press) | |
Guideline: Intermittent iron and folic acid supplementation in non-anaemic pregnant women (in press) | |
Guideline: Use of multiple micronutrient powders for home fortification of foods consumed by infants and children 6–23 months of age | |
Guideline: Use of multiple micronutrient powders for home fortification of foods consumed by pregnant women | |
WHO recommendations for prevention and treatment of pre-eclampsia | |
WHO guidelines on HIV and infant feeding | |
Behavioural interventions | Canadian physical activity and sedentary guidelines for the early years |
Environmental interventions | WHO indoor air quality guidelines: household fuel combustion (ongoing) |
Cochrane systematic review on housing improvements for health and associated socioeconomic outcomes (ongoing) | |
Vaccination | Cholera vaccines: WHO position paper |
Hepatitis B vaccines: WHO position paper | |
Human papillomavirus vaccines: WHO position paper | |
Measles vaccines: WHO position paper | |
Meningococcal vaccines: WHO position paper | |
Pertussis vaccines: WHO position paper | |
Pneumococcal vaccines: WHO position paper | |
Polio vaccines and polio immunization in the | |
pre-eradication era: WHO position paper | |
Rabies vaccines: WHO position paper | |
Rubella vaccines: WHO position paper | |
Vaccines against tick-borne encephalitis: WHO position paper | |
Screening interventions | Guidelines on cervical cancer screening |
Guidelines on breast cancer screening | |
Guidelines on latent TB screening among immigrants and refugees | |
Guidelines for hepatitis B screening among immigrants and refugees | |
Clinical interventions | WHO guidelines for the programmatic management of drug-resistant tuberculosis |
WHO guidelines for mental health, neurological and substance use disorders within WHO Mental Health Gap Action Programme | |
WHO guidelines on prevention and control of cervical cancer (ongoing) | |
WHO guidelines on the management of children with severe malnutrition |